Why Is International Business Machines (IBM) Stock Up +0.73% Today?
Key Takeaways
- IBM shares are trading 0.73% higher on Monday, rising to $239.02 from Friday's close of $237.28, extending a V-shaped recovery from July's post-earnings lows.
- The stock continues to benefit from bargain hunting and an improving technical picture following a brutal July selloff that erased roughly 25% of its market value in a single session.
- Investors appear to be looking past near-term headwinds — including securities fraud investigations and declining mainframe revenue — toward IBM's resilient software growth and expanding AI and quantum computing portfolios.
- Today also marks the record date for IBM's $1.69 quarterly dividend, underscoring the stock's appeal to income-oriented investors amid a yield now hovering near 2.9%.
- Broader market sentiment and sector rotation into beaten-down enterprise technology names have provided additional tailwinds for IBM's ongoing rebound.
Opening Summary
IBM, the Armonk, New York-based technology and consulting giant, is trading modestly higher on Monday, gaining approximately 0.73% to $239.02 as of midday, compared with Friday's closing price of $237.28. While the session's move is not explosive, it marks a continuation of the stock's methodical recovery from its July collapse, when preliminary second-quarter results and a sharp downward revision in growth expectations triggered the company's worst single-day decline since the 1987 market crash. The stock has now clawed back roughly 13% from its 52-week low of $199.19 hit in late July.
A V-Shaped Recovery Gains Traction
Monday's advance is the latest chapter in what technical analysts describe as a V-shaped rebound for IBM. After plummeting from a 52-week high of $332.46 in early June to below $200 in late July, the stock has strung together a series of positive sessions, recovering more than 10% from its trough. The rally has been fueled by a combination of short-covering, value-oriented buying, and growing recognition that the July selloff — while justified by disappointing Q2 results — may have overshot to the downside.
Second-quarter revenue of $17.16 billion, reported on July 22, fell short of the $17.46 billion consensus, dragged down by a 42% year-over-year collapse in IBM Z mainframe revenue and flat consulting growth. Yet software — now IBM's primary growth engine at roughly 45% of revenue — grew 5% year-over-year, with Red Hat accelerating to 11% growth and the company's GenAI book of business surpassing $12.5 billion inception-to-date. Management also maintained its free cash flow growth target of approximately $1 billion for the full year, a signal of underlying financial resilience.
Dividend Record Date and Income Appeal
Monday, August 10, also serves as the record date for IBM's quarterly dividend of $1.69 per share, with payment scheduled for September 10. With the stock yielding approximately 2.9% — elevated after the recent price decline — IBM's 31-year streak of consecutive dividend increases remains a powerful draw for income-focused investors. The dividend is well-covered, consuming roughly 40% of projected 2026 free cash flow of approximately $15.7 billion, providing a margin of safety that income investors prize.
AI, Quantum, and Government Cloud Catalysts
Beyond the recovery trade, IBM has recently unveiled several initiatives that bolster its long-term growth narrative. Its Apptio subsidiary previewed "IBM Apptio AI Value & ROI," a tool designed to help enterprises track and justify AI spending by linking token costs to measurable business outcomes. Separately, IBM's Maximo Application Suite as a Service received FedRAMP Moderate authorization, opening the door for U.S. federal agencies to adopt its cloud-based asset management tools. In quantum computing, IBM announced a definitive agreement to acquire HRL Laboratories and reported progress demonstrating computational advantages on logical quantum circuits in collaboration with the University of Chicago.
Market Context and Trading Activity
Monday's session aligns with a broader tone of stabilization across technology equities. IBM continues to trade below both its 50-day simple moving average of approximately $258 and its 200-day moving average near $255, signaling that the stock remains in a technical downtrend on a longer timeframe despite the near-term rebound. Year-to-date, IBM is still down roughly 20%, dramatically underperforming the S&P 500. However, the stock's low beta of approximately 0.70 has attracted defensive positioning from investors seeking technology exposure with reduced volatility.
What Comes Next for IBM
The path forward for IBM hinges on several key variables. The company's third-quarter earnings report, expected around October 21, will be critical in validating — or undermining — management's assertion that second-half revenue growth will reaccelerate toward the high end of the revised 4% to 5% constant-currency guidance range. Wall Street's consensus rating remains a "Moderate Buy," with an average price target of approximately $265, though several analysts — including Morgan Stanley at $190 and HSBC at $191 — maintain a far more cautious stance. Ongoing securities fraud investigations by multiple law firms into IBM's pre-announcement disclosures represent an unresolved legal overhang, while the pace of deal closures in consulting and the trajectory of the mainframe product cycle will heavily influence sentiment in the months ahead.
Trending AI Robots
Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, each employing distinct strategies, timeframes, and performance metrics calibrated to current market environments. Only the strongest-performing bots under prevailing conditions are highlighted in the curated Trending AI Robots section, giving traders a dynamic view of which algorithms are delivering results right now. Whether you follow momentum, value, or technical patterns, exploring the Trending AI Robots page can help you identify data-driven approaches aligned with today's market conditions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
IBM in +1.38% Uptrend, rising for three consecutive days on September 04, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IBM advanced for three days, in of 375 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where IBM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for IBM just turned positive on July 31, 2026. Looking at past instances where IBM's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 263 cases where IBM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IBM as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.423) is normal, around the industry mean (7.406). P/E Ratio (20.861) is within average values for comparable stocks, (71.230). Projected Growth (PEG Ratio) (2.221) is also within normal values, averaging (1.444). Dividend Yield (0.029) settles around the average of (0.024) among similar stocks. P/S Ratio (3.235) is also within normal values, averaging (149.754).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IBM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of various computer products through the use of advanced information technology
Industry InformationTechnologyServices
Advertisement